114 related articles for article (PubMed ID: 22803141)
1. Heart rate variability in conscious and anesthetized rats under the action of angiotensin converting enzyme inhibitors.
Fateev MM; Sidorov AV; Grigor'eva MV; Rakov AA; Fateeva KM
Bull Exp Biol Med; 2012 Mar; 152(5):590-4. PubMed ID: 22803141
[TBL] [Abstract][Full Text] [Related]
2. The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
Keuneke C; Yacullo R; Metzger R; Hellmann T; Peters J; Ganten D
Eur Heart J; 1990 May; 11 Suppl D():11-6. PubMed ID: 2163328
[TBL] [Abstract][Full Text] [Related]
3. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
[TBL] [Abstract][Full Text] [Related]
4. [A comparative study of the effects of lisinopril and quinapril administered once a day in essential hypertension].
De Cesaris R; Ranieri G; Andriani A; Chiarappa R
Minerva Med; 1990; 81(7-8):541-6. PubMed ID: 2166253
[TBL] [Abstract][Full Text] [Related]
5. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
Brown NJ; Agirbasli M; Vaughan DE
Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of quinapril with enalapril in rats with heart failure.
Watanabe K; Ma M; Wen J; Tachikawa H; Kodama M; Aizawa Y; Yamaguchi K; Takahashi T
Pharmacology; 2004 Jul; 71(3):157-61. PubMed ID: 15161998
[TBL] [Abstract][Full Text] [Related]
7. The effect of 'tissue' and 'plasma' angiotensin converting enzyme inhibitors on overall haemostatic potentials in rats.
Kramkowski K; Mogielnicki A; Chabielska E; Cylwik D; Buczko W
Thromb Res; 2006; 117(5):557-61. PubMed ID: 15985287
[No Abstract] [Full Text] [Related]
8. Low-dose enalapril reduces angiotensin II and attenuates diabetic-induced cardiac and autonomic dysfunctions.
Malfitano C; De Angelis K; Fernandes T; Wichi RB; Rosa K; Pazzine M; Mostarda C; Ronchi FA; Oliveira EM; Casarini DE; Irigoyen MC
J Cardiovasc Pharmacol; 2012 Jan; 59(1):58-65. PubMed ID: 21921804
[TBL] [Abstract][Full Text] [Related]
9. Effect of quinapril or metoprolol on circadian sympathetic and parasympathetic modulation after acute myocardial infarction.
Kontopoulos AG; Athyros VG; Papageorgiou AA; Boudoulas H
Am J Cardiol; 1999 Nov; 84(10):1164-9. PubMed ID: 10569324
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes.
Ma H; Hashizume H; Hara A; Yazawa K; Abiko Y
Jpn J Pharmacol; 1999 Jan; 79(1):17-24. PubMed ID: 10082313
[TBL] [Abstract][Full Text] [Related]
11. Circadian activity of the endogenous fibrinolytic system in stable coronary artery disease: effects of beta-adrenoreceptor blockers and angiotensin-converting enzyme inhibitors.
Sayer JW; Gutteridge C; Syndercombe-Court D; Wilkinson P; Timmis AD
J Am Coll Cardiol; 1998 Dec; 32(7):1962-8. PubMed ID: 9857879
[TBL] [Abstract][Full Text] [Related]
12. Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathy.
Athyros VG; Didangelos TP; Karamitsos DT; Papageorgiou AA; Boudoulas H; Kontopoulos AG
Acta Cardiol; 1998; 53(4):201-9. PubMed ID: 9842405
[TBL] [Abstract][Full Text] [Related]
13. Effects of ACE inhibitors on cardiac angiotensin II and aldosterone in humans: "Relevance of lipophilicity and affinity for ACE".
Ruzicka M; Coletta E; White R; Davies R; Haddad H; Leenen FH
Am J Hypertens; 2010 Nov; 23(11):1179-82. PubMed ID: 20634797
[TBL] [Abstract][Full Text] [Related]
14. Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
Lin CJ; Akarawut W; Smith DE
Pharm Res; 1999 May; 16(5):609-15. PubMed ID: 10350000
[TBL] [Abstract][Full Text] [Related]
15. A comparison of single doses of lisinopril and enalapril in hypertension.
Dews I; Wiseman WT; al-Khawaja I; Stephens J; VandenBurg M
J Hum Hypertens; 1989 Jun; 3 Suppl 1():35-9. PubMed ID: 2550644
[TBL] [Abstract][Full Text] [Related]
16. [Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)].
Skvortsov AA; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Mareev VIu; Belenkov IuN
Ter Arkh; 2005; 77(8):34-43. PubMed ID: 16206603
[TBL] [Abstract][Full Text] [Related]
17. Protective action of angiotensin converting enzyme inhibitors on cardiac hypertrophy in the aortic-banded rat.
Kurosawa Y; Kojima K; Kato M; Ohashi R; Minami K; Narita H
Jpn Heart J; 1999 Sep; 40(5):645-54. PubMed ID: 10888384
[TBL] [Abstract][Full Text] [Related]
18. [Cardiovascular effects of ketamine anesthesia in rats treated with enalapril and propranolol].
Reyes Toso CF; Linares LM; RodrÃguez RR
Medicina (B Aires); 1992; 52(3):240-4. PubMed ID: 1342690
[TBL] [Abstract][Full Text] [Related]
19. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats.
De Gennaro Colonna V; Rossoni G; Rigamonti A; Bonomo S; Manfredi B; Berti F; Muller E
Eur J Pharmacol; 2002 Aug; 450(1):61-6. PubMed ID: 12176110
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment.
Begg EJ; Robson RA; Bailey RR; Lynn KL; Frank GJ; Olson SC
Br J Clin Pharmacol; 1990 Aug; 30(2):213-20. PubMed ID: 2144994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
